World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
43851
World Ranking
7884
National Ranking
4108

Overview

Brenda M. Sandmaier is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on hematology, with significant contributions in hematopoietic stem cell transplantation, acute myeloid leukemia research, and acute lymphoblastic leukemia research.

The scientist's work spans multiple fields within medicine, including public health, environmental and occupational health, oncology, genetics, and radiology, nuclear medicine, and imaging. Within these domains, key topics of their research include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction

Brenda M. Sandmaier has collaborated frequently with several researchers, including:

  • Roland B. Walter
  • Frederick R. Appelbaum
  • Megan Othus
  • Johnnie J. Orozco
  • Partow Kebriaei

The scientist has published extensively in various academic journals, with frequent venues including:

  • Blood
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • Leukemia
  • Blood Advances

Notable recent papers by Brenda M. Sandmaier include:

  • "Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts" (2020, Annals of Internal Medicine)
  • "Acute graft-versus-host disease" (2023, Nature Reviews Disease Primers)
  • "Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML" (2022, Blood)
  • "Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia" (2021, Blood)
  • "Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR" (2021, Leukemia)

Best Publications

  • Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

    Mohamed L. Sorror;Michael B. Maris;Michael B. Maris;Rainer Storb;Rainer Storb;Frederic Baron

  • HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • Reduced mortality after allogeneic hematopoietic-cell transplantation.

    Ted A. Gooley;Jason W. Chien;Jason W. Chien;Steven A. Pergam;Steven A. Pergam;Sangeeta Hingorani;Sangeeta Hingorani

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

    Sergio Giralt;Karen Ballen;Douglas Rizzo;Andreas Bacigalupo

  • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

    Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  • Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

    Marco Mielcarek;Paul J. Martin;Wendy Leisenring;Mary E. D. Flowers

  • Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.

    Boglarka Gyurkocza;Boglarka Gyurkocza;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.

    Takahiro Fukuda;Michael Boeckh;Michael Boeckh;Rachel A. Carter;Rachel A. Carter;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Brenda M. Sandmaier;Barry E. Storer;Michael B. Maris

  • Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

    David G. Maloney;Arthur J. Molina;Firoozeh Sahebi;Keith E. Stockerl-Goldstein

  • Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.

    Mohamed L. Sorror;Michael B. Maris;Barry Storer;Brenda M. Sandmaier

  • Cord-Blood Transplantation in Patients with Minimal Residual Disease

    Filippo Milano;Ted Gooley;Brent Wood;Ann Woolfrey

  • Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

    Mohamed L. Sorror;Sergio Giralt;Brenda M. Sandmaier;Brenda M. Sandmaier;Marcos J.G. de Lima

  • Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

    Frédéric Baron;Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer

  • Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Rainer F. Storb;Brenda M. Sandmaier;Richard T. Maziarz

  • HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

    Michael B. Maris;Dietger Niederwieser;Brenda M. Sandmaier;Barry Storer

  • Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.

    Razvan Diaconescu;Christopher R. Flowers;Barry Storer;Mohamed L. Sorror

  • Hematopoietic cell transplantation (HCT)-specific-comorbidity index: A new tool for risk assessment before allogeneic HCT

    M.L. Sorror;M.B. Maris;M.B. Maris;R.F. Storb;R.F. Storb;F. Baron

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Oliver W. Press
Oliver W. Press University of Washington
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, there are a variety of alternative online degrees and career pathways worth exploring. Many students interested in healthcare choose to pursue a health administration degree online, which opens doors to leadership roles in hospitals, clinics, and other medical organizations.

For those seeking advanced career growth, affordable cheap mha programs can be a strategic option. These master's degrees offer specialized training in managing healthcare systems, making graduates competitive for higher-level managerial positions.

Medical professionals aiming for the highest credentials may consider cheap dnp online programs. A Doctor of Nursing Practice (DNP) degree leads to roles in advanced nursing practice, health policy, and clinical leadership.

Additionally, those interested in pharmaceuticals can find reputable online pharmacy schools. Earning a PharmD online equips graduates for careers ranging from clinical pharmacists to research and academia.

Regardless of your interests, online healthcare degrees offer flexibility and affordability, making it easier to tailor your education to your career goals.

Best Scientists Citing Brenda M. Sandmaier

Trending Scientists